Evidence map›Paper›PMID 30325430›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2019

Abundant a proliferation-inducing ligand (APRIL)-producing macrophages contribute to plasma cell accumulation in immunoglobulin G4-related disease.

Takahiro Kawakami, Ichiro Mizushima, Kazunori Yamada, Hiroshi Fujii, Kiyoaki Ito, Tetsuhiko Yasuno, Shozo Izui, Masakazu Yamagishi, Bertrand Huard, Mitsuhiro Kawano

Open access · hybridAbstract read
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Inhibiting B cell activating factor attenuates preeclamptic symptoms in placental ischemic rats.American journal of reproductive immunology (New York, N.Y. : 1989) · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. [Immunoglobulin-G4-related disease].Zeitschrift fur Rheumatologie · 2022
    Review
  12. IgG4-related diseases of the digestive tract.Nature reviews. Gastroenterology & hepatology · 2022
    Review
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Takahiro KawakamiDivision of Rheumatology, Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Ichiro MizushimaDivision of Rheumatology, Department of Internal Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Kazunori YamadaDivision of Rheumatology, Department of Internal Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Hiroshi FujiiDivision of Rheumatology, Department of Internal Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Kiyoaki ItoDivision of Rheumatology, Department of Internal Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Tetsuhiko YasunoDivision of Nephrology and Rheumatology, Department of Internal Medicine, Fukuoka University, Fukuoka, Japan.
Shozo IzuiDepartment of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Masakazu YamagishiDivision of Cardiology, Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Bertrand HuardInstitute for Advanced Biosciences, University Grenoble-Alpes, INSERM U1209, UMR 5309, La Tronche, France.
Mitsuhiro KawanoDivision of Rheumatology, Department of Internal Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Kanazawa University Hospital · JPKanazawa University · JPFukuoka University · JPInserm · FRUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to investigate the contribution of a proliferation-inducing ligand (APRIL), a member of the tumor necrosis factor (TNF) superfamily implicated in plasma cell survival, to the development of plasma cell-rich lesions in immunoglobulin G4-related disease (IgG4-RD).

methodsWe performed immunohistochemical staining for APRIL with Stalk-1 and Aprily-8 antibodies specifically recognizing APRIL-producing cells and secreted APRIL, respectively, in renal and submandibular lesions of IgG4-RD in comparison with those of Sjögren's syndrome and sialolithiasis.

resultsNumerous Stalk-1-positive APRIL-producing cells were detectable in lesions of IgG4-RD. These cells, identified as CD163-positive M2 macrophages, secreted APRIL that distributed close to and even on infiltrating plasma cells. In contrast, APRIL-producing cells and the secreted form of APRIL were rarely detectable in lesions of Sjögren's syndrome or sialolithiasis. Notably, APRIL expression decreased concomitantly with the level of plasma cell infiltration after successful glucocorticoid treatment.

conclusionsAbundant infiltration into tissue lesions of APRIL-producing M2 macrophages and retention of secreted APRIL in plasma-cell-rich areas support a role for APRIL in the pathogenesis of plasma cell-rich lesions in IgG4-RD.

Indexed as

AdultAgedAged, 80 and overCell ProliferationFemaleHumansImmunoglobulin GImmunoglobulin G4-Related DiseaseImmunohistochemistryKidneyMacrophagesMaleMiddle AgedPlasma CellsRetrospective StudiesSalivary Gland CalculiImmunoglobulin GTNFSF13 protein, humanTumor Necrosis Factor Ligand Superfamily Member 13APRILIgG4–related diseasemacrophages

Identifiers

PMID30325430
PMCPMC6545467
OpenAlexW2896253836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.